Exalenz Bioscience Acquired for $49M
19.02.20 | Golan Hazani
This site uses cookies to ensure the best viewing experience for our readers.
Mori Arkin
5 stories about Mori Arkin
Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company
19.02.20 | Golan Hazani
Merck and WuXi AppTec Announce Launch of Biotech Incubator in Israel
20.02.18 | Meir Orbach
Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO
31.08.17 | Dror Reich
Anti-Acne Drug Developer Plans Nasdaq IPO
15.08.17 | Golan Hazani
Tag does not exist. Please try again.